产品详情
靶点信息
c-Kit | VEGFR3 | VEGFR2 | PDGFRα | |
1 nM | 4 nM | 6 nM | 15 nM |
In vitro | DMSO | 71 mg/mL (173.24 mM) | |
Water | Insoluble | ||
Ethanol | 1 mg/mL (2.44 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.4 mL | 122.01 mL | 244.02 mL |
0.5 mM | 4.88 mL | 24.4 mL | 48.8 mL |
1 mM | 2.44 mL | 12.2 mL | 24.4 mL |
5 mM | 0.49 mL | 2.44 mL | 4.88 mL |
*The above data is based on the productmolecular weight 409.8 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10903 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 409.8 |
Formula | C20H16ClN5O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 332012-40-5 |
Synonyms | BAY57-9352 |
SMILES | CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl |
产品资料
产品标签
Product Questions
Product Questions
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
CYC116 (CYC-116)
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Flumatinib mesylate
Flumatinib mesylate以时间和剂量依赖性的方式降低U266细胞中C-MYC,HIF-1a和VEGF的表达,因此甲磺酸氟马替尼可能…
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂,抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6,0.1和0.1 μM。
Vatalanib (PTK787) 2HCl
Vatalanib (PTK787) 2HCl是一种小分子蛋白激酶抑制剂,可抑制抑制所有已知VEGF受体以及血小板衍生的生长因子…
Buflomedil HCl
Buflomedil HCl是一种用于治疗外周血管疾病的血管活性剂。